6892 fundamentals
An in-depth look to TAIWAN BIO THERAPEUTICS CO LTD operating, investing, and financing activities
6892 free cash flow for Q4 24 is -95.81 M TWD. For 2024, 6892 free cash flow was -322.56 M TWD and operating cash flow was -252.4 M TWD.
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q3 '24
Q4 '24
TTM